UK: +44 (0) 1283 753 220
US: +1 908 829 4146
Bionical, a global partner to the pharmaceutical and biotech industry has announced that Alexander Santos has joined the team as a Vice President of Business Development - Clinical.
This move comes after Bionical announced the acquisition of Emas Pharma, a global clinical research organization, in November 2016 to complement the existing clinical trial services division on which Bionical was founded. Strategically, Bionical has bridged clinical services, bringing together both the clinical research and clinical trials divisions under one umbrella to create a more robust and streamlined service to its clients.
For Alexander Santos, a veteran to the pharmaceutical industry with over twenty years of experience in a clinical setting, joining Bionical was a natural fit for both him and the company. On becoming part of the team Alex says, “I was drawn to the company’s mission to improve patient outcomes, and the structure of the clinical division was setup in a way that would truly help our clients accomplish this. The integration of clinical services has structurally been a welcome change that really benefits our clients. I’m also looking forward to working alongside such a strong and dedicated staff at Bionical.”
Executive Director, Business Development, Jonathan Waring-Hughes comments, “Alex’s vast experience in the clinical arena have already made him a valuable asset to Bionical. We look forward to having him further develop and foster the clinical partnerships we pride ourselves on as a company. We believe this in turn will help us provide even better solutions for our clients.”
All rights reserved © 2019 Bionical Ltd.